Celebrating 25 years Est 1999-2024
*Across 3 years $2158.56 only $755.50
SOUTH SAN FRANCISCO, Calif., Nov. 14, 2024 (GLOBE NEWSWIRE) -- Alector, Inc. (Nasdaq: ALEC), a clinical-stage...
Data from INVOKE-2, evaluating TREM2 agonist candidate AL002 in patients with early Alzheimerβs disease (AD...
--Participant baseline characteristics in INFRONT-3 suggest a representative study population that enables...
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.